| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |